| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/03/2011 | US20110029030 Methods and Compositions for Treating a Disease Condition in a Subject |
| 02/03/2011 | US20110028807 Contact lens for collecting tears and detecting at least one analyte |
| 02/03/2011 | US20110028552 Mexiletine amino acid and peptide prodrugs and uses thereof |
| 02/03/2011 | US20110028544 Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| 02/03/2011 | US20110028543 Formulations and methods of using nitric oxide mimetics in cancer treatment |
| 02/03/2011 | US20110028538 Methods and compositions related to tr4 ligand |
| 02/03/2011 | US20110028531 Novel sirna compounds for inhibiting rtp801 |
| 02/03/2011 | US20110028526 Valsartan solid oral dosage forms and methods of making such formulations |
| 02/03/2011 | US20110028523 Selective Alpha 2B/2C Agonists |
| 02/03/2011 | US20110028514 Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 02/03/2011 | US20110028512 Bis-heterocyclic imidazolyl compounds |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028506 Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives |
| 02/03/2011 | US20110028503 Compositions and methods for inhibition of the jak pathway |
| 02/03/2011 | US20110028496 Deuterium-enriched pyrimidine compounds and derivatives |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028479 Substituted pyrrolotriazines and their use |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
| 02/03/2011 | US20110028472 Thienopyrimidines |
| 02/03/2011 | US20110028467 Heterocyclic derivatives |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028462 Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
| 02/03/2011 | US20110028438 Medical use of 3-2,2,2-trimethylhydrazinium propionate salts. |
| 02/03/2011 | US20110028429 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia |
| 02/03/2011 | US20110028420 Regression of Established Atherosclerotic Plaques, and Treating Sudden-Onset Asthma Attacks, using PARP Inhibitors |
| 02/03/2011 | US20110028417 Macrocyclic Compounds and Methods of Use Thereof |
| 02/03/2011 | US20110028398 Methods for treating and limiting fibrotic disorders and keloids |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027371 Nanoparticulate statin formulations and novel statin combinations |
| 02/03/2011 | US20110027367 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/03/2011 | US20110027365 Patch Formulation For External Use |
| 02/03/2011 | US20110027359 Novel Pharmaceutical Compositions Comprising Levetiracetam |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027348 Composition and method inhibiting inflammation |
| 02/03/2011 | US20110027342 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | US20110027337 Protease inhibitor |
| 02/03/2011 | US20110027336 Coatings for implantable devices comprising polymers of lactic acid and methods for fabricating the same |
| 02/03/2011 | US20110027325 Orally-administered agent |
| 02/03/2011 | US20110027305 Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus |
| 02/03/2011 | US20110027257 Clottable concentrate of platelet growth factors and preparation method thereof |
| 02/03/2011 | US20110027234 Methods for identification and selection of human embryonic stem cell derived cells |
| 02/03/2011 | US20110027220 Interleukin-1 Conjugates and Uses Thereof |
| 02/03/2011 | US20110027204 title compound is adapalene; acne gel or cream |
| 02/03/2011 | US20110027188 Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110023870 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 02/03/2011 | CA2774715A1 Fused heterocyclic compounds as ion channel modulators |
| 02/03/2011 | CA2769223A1 Sticky soft gel for treating poultry |
| 02/03/2011 | CA2769147A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/03/2011 | CA2766535A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 02/03/2011 | CA2766533A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients |
| 02/02/2011 | EP2280019A1 Antisense modulation of C-reactive protein expression |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279738A1 The use of quaternary pyridinium salts as vasoprotective agents |
| 02/02/2011 | EP2279734A1 Composition for preventing cardiovascular event in high-risk patient |
| 02/02/2011 | EP2279196A2 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/02/2011 | EP2279191A1 Substituted 2-phenyl-pyridine derivatives |
| 02/02/2011 | EP2279009A2 Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure |
| 02/02/2011 | EP2279003A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 02/02/2011 | EP2278981A2 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
| 02/02/2011 | EP2278976A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors |
| 02/02/2011 | EP2278975A1 Novel nitroso compounds as nitroxyl donors and methods of use thereof |
| 02/02/2011 | EP2032593B1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes |
| 02/02/2011 | EP1940445B1 Stem cell derived paracrine factor h12 for use in reducing cell death or enhancing tissue repair |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN1899615B Preparation for the prophylaxis of restenose |
| 02/02/2011 | CN101965352A Pyripyropene derivative having acat2-inhibiting activity |
| 02/02/2011 | CN101965337A Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 02/02/2011 | CN101965213A Egg products with components recognized for reducing the levels of cholesterol in people and/or improving their health |
| 02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
| 02/02/2011 | CN101965184A Synthetic triterpenoids and methods of use in the treatment of disease |
| 02/02/2011 | CN101965179A Hemorrhoid treatment device |
| 02/02/2011 | CN101962602A Health beer made from six Chinese medicinal herbs |
| 02/02/2011 | CN101962404A Protein used for treating hemangioma |
| 02/02/2011 | CN101962365A Aminoindazole derivatives as protein-kinase inhibitors |
| 02/02/2011 | CN101961493A Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 02/02/2011 | CN101961491A Novel blood pressure and blood fat reduction composition |
| 02/02/2011 | CN101961486A 一种滴眼液及其制备方法 One kind of eye drops and its preparation method |
| 02/02/2011 | CN101961460A Chinese medicinal health-care composition and preparation method thereof |
| 02/02/2011 | CN101961459A Oral medicament for treating hemiplegia |
| 02/02/2011 | CN101961447A Novel preparation method, preparation and application of Chinese medicinal composition |
| 02/02/2011 | CN101961434A Rheumatic Xintong powder |
| 02/02/2011 | CN101961410A Chinese medicament for treating diabetic heart disease |
| 02/02/2011 | CN101961409A Bathing effervescent tablets for improving qi deficiency and blood stasis type chest numbness |
| 02/02/2011 | CN101961405A Method for testing content of pinoresinol diglucoside in compound eucommia bark tablet |
| 02/02/2011 | CN101961403A Combined Chinese medicinal ointment for treating hemorrhoids |
| 02/02/2011 | CN101961398A Chinese medicinal oral liquid for treating cardiovascular and cerebrovascular diseases |
| 02/02/2011 | CN101961393A Chinese medicinal composition for treating haemorrhoids and preparation method thereof |
| 02/02/2011 | CN101961382A Medicinal composition for treating cardiovascular and cerebrovascular diseases and detection method thereof |